medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 6

<< Back Next >>

Rev Mex Urol 2022; 82 (6)

Hybrid renal tumor and its atypical spectrum: Case report and review of the literature

Sánchez-Gómez LC, Cruz-Cruz NR, Arroyo-López NP
Full text How to cite this article

Language: Spanish
References: 8
Page:
PDF size: 361.75 Kb.


Key words:

Renal mass, renal oncocytoma, chromophobe renal cell carcinoma, hybrid oncocytic/ chromophobe tumor.

ABSTRACT

Clinical case: Hybrid renal tumor is defined as that neoplasm whose components are given by the presence of oncocytes (oncocytoma) and chromophobe cells whose preoperative diagnosis is challenging due to its great similarity with typical oncocytoma. Its modalities of presentation include hereditary and sporadic, the first being the most frequent, associated with the involvement of other organs such as the skin and the lungs.
Clinical implications: We present the case of a 9-year-old female patient, a primary school student, who was incidentally found to have a mass on the left flank, not painful on palpation, fixed, of approximately 8 cm, for which Ultrasound, abdominal tomography, and renal angiotomography were performed, confirming the presence of a large, well-defined left renal mass, heterogeneous by area of central necrosis, with no evidence of infiltration to adjacent structures or vascular invasion whose histopathological report revealed hybrid renal oncocytoma, for which is taken to laparoscopic total nephrectomy, presenting adequate evolution in its follow-up.
Relevance: Familiarizing ourselves with the spectrum of renal masses in schoolchildren is of vital importance since they are benign neoplasms, which prevents the use of necessary measures.
Conclusion: Rapid identification allows timely surgical lesions with less morbidity in patients, so it is important that different specialists know their imaging findings.


REFERENCES

  1. Zhao S, Shi J, Yang R, Zhang X, Zhao W, SunZ. Ultrasonography findings for the diagnosisof renal oncocytoma. J Med Ultrasonics. 2022;49(2):211–6. doi: https://doi.org/10.1007/s10396-021-01179-y

  2. Marko J, Craig R, Nguyen A, Udager AM, WolfmanDJ. Chromophobe Renal Cell Carcinomawith Radiologic-Pathologic Correlation. RadioGraphics. 2021;41(5):1408–19. doi: https://doi.org/10.1148/rg.2021200206

  3. Abdessater M, Kanbar A, Comperat E, Dupont-Athenor A, Alechinsky L, Mouton M, et al. RenalOncocytoma: An Algorithm for Diagnosis andManagement. Urology. 2020;143:173–80. doi:https://doi.org/10.1016/j.urology.2020.05.047

  4. Nicolau C, Antunes N, Paño B, Sebastia C.Imaging Characterization of Renal Masses.Medicina. 2021;57(1):51. doi: https://doi.org/10.3390/medicina57010051

  5. Valdés Olmos RA, de Geus-Oei L-F, TichelerCHJM, Bloem JL. From Incidentaloma toOncocytoma: A Role for Hybrid MolecularImaging in Characterising Renal Masses? EurUrol. 2016;69(3):417–8. doi: https://doi.org/10.1016/j.eururo.2015.09.040

  6. Giambelluca D, Pellegrino S, Midiri M, SalvaggioG. The “central stellate scar” sign in renaloncocytoma. Abdom Radiol. 2019;44(5):1942–3. doi: https://doi.org/10.1007/s00261-019-01899-3

  7. Mileto A, Potretzke TA. Standardized Evaluationof Small Renal Masses Using the MRI Clear CellLikelihood Score. Radiology. 2022;303(3):600–2. doi: https://doi.org/10.1148/radiol.220054

  8. Moch H, Ohashi R. Chromophobe renal cellcarcinoma: current and controversial issues.Pathology. 2021;53(1):101–8. doi: https://doi.org/10.1016/j.pathol.2020.09.015




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2022;82